Renal protective role of atrial natriuretic peptide in acute sodium overload-induced inflammatory response

被引:17
作者
Roson, Maria Ines
Toblli, Jorge E.
Della Penna, Silvana L.
Gorzalczany, Susana
Pandolfo, Marcela
Cavallero, Susana
Fernandez, Belisario E.
机构
[1] Univ Buenos Aires, Fac Farm & Bioquim, Catedra Fisiopatol, Sch Pharm & Biochem,Dept Pathophysiol, RA-1113 Buenos Aires, DF, Argentina
[2] Univ Buenos Aires, Sch Pharm & Biochem, Dept Pharmacol, RA-1113 Buenos Aires, DF, Argentina
[3] Univ Buenos Aires, Sch Pharm & Biochem, Dept Clin Chem, RA-1113 Buenos Aires, DF, Argentina
[4] German Hosp, Expt Med Lab, Buenos Aires, DF, Argentina
关键词
atrial natriuretic peptide; sodium overload; angiotensin II;
D O I
10.1159/000098148
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: The present study was performed to explore the effect of exogenous infusions of atrial natriuretic peptide (ANP) on the early inflammatory response during acute sodium overload in normal rats. Methods: Sprague Dawley rats were exposed to acute sodium overload (Na 1.5 M). Non-hypotensive doses of ANP (1 and 5 mu g center dot kg(-1) center dot h(-1)) were infused simultaneously with sodium or after sodium infusion in order to evaluate prevention or reversion of the inflammatory response, respectively. We determined inflammation markers in renal tissue by immunohistochemistry. Results: Creatinine clearance was not reduced in any case. Sodium tubular reabsorption increased after sodium overload (334.3 +/- 18.7 vs. control 209.6 +/- 27.0 mEq center dot min(-1), p < 0.05) without changes in mean arterial pressure. This increase was prevented (228.9 +/- 26.4; p < 0.05) and reversed (231.5 +/- 13.9; p < 0.05) by ANP-5 mu g center dot kg(-1) center dot h(-1). Sodium overload increased the expression of: RANTES (38.4.3 +/- 0.8 vs. 2.9 +/- 0.6%, p < 0.001), transforming-growth-factor-beta 1 (35.3 +/- 1.0 vs. 5.0 +/- 0.7%, p < 0.001), alpha-smooth muscle actin (15.6 +/- 0.7 vs. 3.1 +/- 0.3%, p < 0.001), NF-kappa B (9.4 +/- 1.3 to 2.2 +/- 0.5 cells/mm(2), p < 0.001), HIF-1 alpha (38.2 +/- 1.7 to 8.4 +/- 0.8 cells/mm(2), p < 0.001) and angiotensin II (35.9 +/- 1.3 to 8.2 +/- 0.5%, p < 0.001). ANP-5 mu g center dot kg(-1) center dot h(-1) prevented and reversed inflammation: RANTES (9.2 +/- 0.5 and 6.9 +/- 0.7, p < 0.001); transforming growth factor-beta(1) (13.2 +/- 0.7 and 10.2 +/- 0.5, p < 0.001) and alpha-smooth muscle actin (4.1 +/- 0.4 and 5.2 +/- 0.4, p < 0.001). Both prevention and reversion by ANP were associated with downregulation of NF-kappa B (3.2 +/- 0.4 and 2.8 +/- 0.5, p < 0.001) and angiotensin II (8.2 +/- 0.5 and 9.1 +/- 0.7, p < 0.001) and diminished hypoxia evaluated through HIF-1 alpha expression (8.4 +/- 0.8 and 8.8 +/- 0.7, p < 0.001). Conclusion: Our study provides evidence supporting a protective role of ANP in both prevention and reversion of renal inflammation in rats with acute sodium overload. Copyright (c) 2006 S. Karger AG, Basel.
引用
收藏
页码:590 / 601
页数:12
相关论文
共 40 条
[11]   THE EFFECTS OF HUMAN ATRIAL 28-AMINO ACID PEPTIDE ON SYSTEMIC AND RENAL HEMODYNAMICS IN ANESTHETIZED RATS [J].
HIRATA, Y ;
ISHII, M ;
SUGIMOTO, T ;
MATSUOKA, H ;
SUGIMOTO, T ;
KANGAWA, K ;
MATSUO, H .
CIRCULATION RESEARCH, 1985, 57 (04) :634-639
[12]   USE OF AVIDIN-BIOTIN-PEROXIDASE COMPLEX (ABC) IN IMMUNOPEROXIDASE TECHNIQUES - A COMPARISON BETWEEN ABC AND UNLABELED ANTIBODY (PAP) PROCEDURES [J].
HSU, SM ;
RAINE, L ;
FANGER, H .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1981, 29 (04) :577-580
[13]   Direct ANP inhibition of hypoxia-induced inflammatory pathways in pulmonary microvascular and macrovascular endothelial monolayers [J].
Irwin, DC ;
van Patot, MCT ;
Tucker, A ;
Bowen, R .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2005, 288 (05) :L849-L859
[14]   Autocrine regulation of inducible nitric-oxide synthase in macrophages by atrial natriuretic peptide [J].
Kiemer, AK ;
Vollmar, AM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (22) :13444-13451
[15]   Induction of IκB:: atrial natriuretic peptide as a regulator of the NF-κB pathway [J].
Kiemer, AK ;
Weber, NC ;
Vollmar, AM .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 295 (05) :1068-1076
[16]   Inhibition of p38 MAPK activation via induction of MKP-1 -: Atrial natriuretic peptide reduces TNF-α-induced actin polymerization and endothelial permeability [J].
Kiemer, AK ;
Weber, NC ;
Fürst, R ;
Bildner, N ;
Kulhanek-Heinze, S ;
Vollmar, AM .
CIRCULATION RESEARCH, 2002, 90 (08) :874-881
[17]   Inhibition of cyclooxygenase-2 by natriuretic peptides [J].
Kiemer, AK ;
Lehner, MD ;
Hartung, T ;
Vollmar, AM .
ENDOCRINOLOGY, 2002, 143 (03) :846-852
[18]  
Kiemer Alexandra K., 2005, Current Medicinal Chemistry - Cardiovascular & Hematological Agents, V3, P11
[19]   Reduced oxygen tension increases atrial natriuretic peptide release from atrial cardiocytes [J].
Klinger, JR ;
Pietras, L ;
Warburton, R ;
Hill, NS .
EXPERIMENTAL BIOLOGY AND MEDICINE, 2001, 226 (09) :847-853
[20]   ATRIAL NATRIURETIC FACTOR - A CIRCULATING HORMONE STIMULATED BY VOLUME LOADING [J].
LANG, RE ;
THOLKEN, H ;
GANTEN, D ;
LUFT, FC ;
RUSKOAHO, H ;
UNGER, T .
NATURE, 1985, 314 (6008) :264-266